TEST BANK
Pharmacology and the
Nursing Process 8th
Edition Linda Lane Lilley,
Shelly Rainforth Collins,
Julie S. Snyder
,Contents
Chapter 01: The Nursing Process and Drug Therapy ..................................................................................... 4
Chapter 02: Pharmacologic Principles ........................................................................................................... 8
Chapter 03: Lifespan Considerations ........................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations .............................................................................. 20
Chapter 05: Medication Errors: Preventing and Responding ...................................................................... 26
Chapter 06: Patient Education and Drug Therapy ....................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements .............................................. 34
Chapter 08: Gene Therapy and Pharmacogenomics ................................................................................... 38
Chapter 09: Photo Atlas of Drug Administration ......................................................................................... 41
Chapter 10: Analgesic Drugs ........................................................................................................................ 50
Chapter 11: General and Local Anesthetics ................................................................................................. 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................. 61
Chapter 13: Central Nervous System Stimulants and Related Drugs .......................................................... 66
Chapter 14: Antiepileptic Drugs ................................................................................................................... 70
Chapter 15: Antiparkinson Drugs ................................................................................................................. 76
Chapter 16: Psychotherapeutic Drugs ......................................................................................................... 81
Chapter 17: Substance Abuse ...................................................................................................................... 88
Chapter 18: Adrenergic Drugs ...................................................................................................................... 93
Chapter 19: Adrenergic-Blocking Drugs ....................................................................................................... 98
Chapter 20: Cholinergic Drugs ................................................................................................................... 103
Chapter 21: Cholinergic-Blocking Drugs .................................................................................................... 108
Chapter 22: Antihypertensive Drugs ...........................................................................................................113
Chapter 23: Antianginal Drugs ................................................................................................................... 119
Chapter 24: Heart Failure Drugs ................................................................................................................ 125
Chapter 25: Antidysrhythmic Drugs ........................................................................................................... 131
Chapter 26: Coagulation Modifier Drugs ................................................................................................... 137
Chapter 27: Antilipemic Drugs ................................................................................................................... 143
Chapter 28: Diuretic Drugs..........................................................................................................................148
Chapter 29: Fluids and Electrolytes ........................................................................................................... 154
Chapter 30: Pituitary Drugs.........................................................................................................................160
,Chapter 31: Thyroid and Antithyroid Drugs ............................................................................................... 163
Chapter 32: Antidiabetic Drugs .................................................................................................................. 168
Chapter 33: Adrenal Drugs......................................................................................................................... 177
Chapter 34: Women’s Health Drugs .......................................................................................................... 181
Chapter 35: Men’s Health Drugs .................................................................................................................188
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants .......................................... 193
Chapter 37: Respiratory Drugs ....................................................................................................................198
Chapter 38: Antibiotics Part 1 .................................................................................................................... 204
Chapter 39: Antibiotics Part 2 .................................................................................................................... 211
Chapter 40: Antiviral Drugs ........................................................................................................................ 216
Chapter 41: Antitubercular Drugs .............................................................................................................. 221
Chapter 42: Antifungal Drugs..................................................................................................................... 226
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ............................................................ 231
Chapter 44: Anti-inflammatory and Antigout Drugs.................................................................................. 236
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs ...................... 242
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs ........... 248
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ........................................................ 253
Chapter 48: Immunosuppressant Drugs .................................................................................................... 258
Chapter 49: Immunizing Drugs .................................................................................................................. 263
Chapter 50: Acid-Controlling Drugs ........................................................................................................... 268
Chapter 51: Bowel Disorder Drugs............................................................................................................. 274
Chapter 52: Antiemetic and Antinausea Drugs..........................................................................................281
Chapter 53: Vitamins and Minerals ........................................................................................................... 286
Chapter 54: Anemia Drugs ......................................................................................................................... 292
Chapter 55: Nutritional Supplements ........................................................................................................ 299
Chapter 56: Dermatologic Drugs ............................................................................................................... 304
Chapter 57: Ophthalmic Drugs................................................................................................................... 310
Chapter 58: Otic Drugs ............................................................................................................................... 315
, Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
diagnosis?
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements
such as “I’m upset about having to test my blood sugars.”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
upset about having to test my blood sugars.”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new
drug therapy” is missing the “as evidenced by” portion of defining characteristics. The statement
beginning “Anxiety related to anxious feelings” is incorrect because the “related to” section is
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 7
TOP: NURSING PROCESS: Nursing Diagnosis
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and
gave the medication 2 hours after the scheduled dose was due. What type of problem does this
represent?
a. “Right time”
b. “Right dose”
c. “Right route”
d. “Right medication”
ANS: A
“Right time” is correct because the medication was given more than 30 minutes after the
scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the
medication administration is scheduled. “Route” is incorrect because the route is not affected.
“Medication” is incorrect because the medication ordered will not change.
DIF: COGNITIVE LEVEL: Applying (Application) REF: p. 11
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
and documenting the patient’s therapeutic response to the medication. Which phase of the
nursing process do these actions illustrate?
a. Nursing diagnosis
, b. Planning
c. Implementation
d. Evaluation
ANS: D
Monitoring the patient’s progress, including the patient’s response to the medication, is part of
the evaluation phase. Planning, implementation, and nursing diagnosis are not illustrated by this
example.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: pp. 13-14
TOP: NURSING PROCESS: Evaluation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
4. The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus. Which
statement best illustrates an outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient will adhere to the new insulin treatment regimen.
d. The patient will demonstrate correct blood glucose testing technique.
ANS: D
“Demonstrating correct blood glucose testing technique” is a specific and measurable outcome
criterion. “Following instructions” and “not experiencing complications” are not specific criteria.
“Adhering to new regimen” would be difficult to measure.
DIF: COGNITIVE LEVEL: Applying (Application) REF: p. 8
TOP: NURSING PROCESS: Planning
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
5. Which activity best reflects the implementation phase of the nursing process for the patient who
is newly diagnosed with hypertension?
a. Providing education on keeping a journal of blood pressure readings
b. Setting goals and outcome criteria with the patient’s input
c. Recording a drug history regarding over-the-counter medications used at home
d. Formulating nursing diagnoses regarding deficient knowledge related to the new
treatment regimen
ANS: A
Education is an intervention that occurs during the implementation phase. Setting goals and
outcomes reflects the planning phase. Recording a drug history reflects the assessment phase.
Formulating nursing diagnoses reflects analysis of data as part of planning.
DIF: COGNITIVE LEVEL: Applying (Application) REF: pp. 8-9
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
6. The medication order reads, “Give ondansetron (Zofran) 4 mg, 30 minutes before beginning
chemotherapy to prevent nausea.” The nurse notes that the route is missing from the order. What
is the nurse’s best action?
, a. Give the medication intravenously because the patient might vomit.
b. Give the medication orally because the tablets are available in 4-mg doses.
c. Contact the prescriber to clarify the route of the medication ordered.
d. Hold the medication until the prescriber returns to make rounds.
ANS: C
A complete medication order includes the route of administration. If a medication order does not
include the route, the nurse must ask the prescriber to clarify it. The intravenous and oral routes
are not interchangeable. Holding the medication until the prescriber returns would mean that the
patient would not receive a needed medication.
DIF: COGNITIVE LEVEL: Applying (Application) REF: p. 12
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
7. When the nurse considers the timing of a drug dose, which factor is appropriate to consider when
deciding when to give a drug?
a. The patient’s ability to swallow
b. The patient’s height
c. The patient’s last meal
d. The patient’s allergies
ANS: C
The nurse must consider specific pharmacokinetic/pharmacodynamic drug properties that may be
affected by the timing of the last meal. The patient’s ability to swallow, height, and allergies are
not factors to consider regarding the timing of the drug’s administration.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 12
TOP: NURSING PROCESS: Assessment
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
8. The nurse is performing an assessment of a newly admitted patient. Which is an example of
subjective data?
a. Blood pressure 158/96 mm Hg
b. Weight 255 pounds
c. The patient reports that he uses the herbal product ginkgo.
d. The patient’s laboratory work includes a complete blood count and urinalysis.
ANS: C
Subjective data include information shared through the spoken word by any reliable source, such
as the patient. Objective data may be defined as any information gathered through the senses or
that which is seen, heard, felt, or smelled. A patient’s blood pressure, weight, and laboratory tests
are all examples of objective data.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 6
TOP: NURSING PROCESS: Assessment
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
MULTIPLE RESPONSE
,1. When giving medications, the nurse will follow the rights of medication administration. The
rights include the right documentation, the right reason, the right response, and the patient’s right
to refuse. Which of these are additional rights? (Select all that apply.)
a. Right drug
b. Right route
c. Right dose
d. Right diagnosis
e. Right time
f. Right patient
ANS: A, B, C, E, F
Additional rights of medication administration must always include the right drug, right dose,
right time, right route, and right patient. The right diagnosis is incorrect.
DIF: COGNITIVE LEVEL: Remembering (Knowledge) REF: p. 9
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
2. Place the phases of the nursing process in the correct order, with 1 as the first phase and 5 as the
last phase. (Select all that apply.)
a. Planning
b. Evaluation
c. Assessment
d. Implementation
e. Nursing Diagnoses
ANS: A, B, C, D, E
The nursing process is an ongoing process that begins with assessing and continues with
diagnosing, planning, implementing, and evaluating.
DIF: COGNITIVE LEVEL: Applying (Application) REF: p. 4
TOP: NURSING PROCESS: General
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
, Chapter 02: Pharmacologic Principles 8
Chapter 02: Pharmacologic Principles
MULTIPLE CHOICE
1. The patient is receiving two different drugs. At current dosages and dosage forms, both drugs are
absorbed into the circulation in identical amounts. Which term is used to identify this principle?
a. Bioequivalent
b. Synergistic
c. Prodrugs
d. Steady state
ANS: A
Two drugs absorbed into the circulation in the same amount (in specific dosage forms) have the
same bioavailability; thus, they are bioequivalent. A drug’s steady state is the physiologic state in
which the amount of drug removed via elimination is equal to the amount of drug absorbed from
each dose. The term synergistic refers to two drugs, given together, with a resulting effect that is
greater than the sum of the effects of each drug given alone. A prodrug is an inactive drug
dosage form that is converted to an active metabolite by various biochemical reactions once it is
inside the body.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 21
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. When given an intravenous medication, the patient says to the nurse, “I usually take pills. Why
does this medication have to be given in the arm?” What is the nurse’s best answer?
a. “The medication will cause fewer adverse effects when given intravenously.”
b. “The intravenous medication will have delayed absorption into the body’s tissues.”
c. “The action of the medication will begin sooner when given intravenously.”
d. “There is a lower chance of allergic reactions when drugs are given intravenously.”
ANS: C
An intravenous (IV) injection provides the fastest route of absorption. The IV route does not
affect the number of adverse effects, nor does it cause delayed tissue absorption (it results in
faster absorption). The IV route does not affect the number of allergic reactions.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 22
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. The nurse is administering parenteral drugs. Which statement is true regarding parenteral drugs?
a. Parenteral drugs bypass the first-pass effect.
b. Absorption of parenteral drugs is affected by reduced blood flow to the stomach.
c. Absorption of parenteral drugs is faster when the stomach is empty.
d. Parenteral drugs exert their effects while circulating in the bloodstream.
ANS: A
, Chapter 02: Pharmacologic Principles 9
Drugs given by the parenteral route bypass the first-pass effect. Reduced blood flow to the
stomach and the presence of food in the stomach apply to enteral drugs (taken orally), not to
parenteral drugs. Parenteral drugs must be absorbed into cells and tissues from the circulation
before they can exert their effects; they do not exert their effects while circulating in the
bloodstream.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 22
TOP: NURSING PROCESS: General
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
4. When monitoring the patient receiving an intravenous infusion to reduce blood pressure, the
nurse notes that the patient’s blood pressure is extremely low, and the patient is lethargic and
difficult to awaken. This would be classified as which type of adverse drug reaction?
a. Adverse effect
b. Allergic reaction
c. Idiosyncratic reaction
d. Pharmacologic reaction
ANS: D
A pharmacologic reaction is an extension of a drug’s normal effects in the body. In this case, the
antihypertensive drug lowered the patient’s blood pressure levels too much. The other options do
not describe a pharmacologic reaction. An adverse effect is a predictable, well-known adverse
drug reaction that results in minor or no changes in patient management. An allergic reaction
(also known as a hypersensitivity reaction) involves the patient’s immune system. An
idiosyncratic reaction is unexpected and is defined as a genetically determined abnormal
response to normal dosages of a drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 32
TOP: NURSING PROCESS: General
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
5. The nurse is reviewing pharmacology terms for a group of newly graduated nurses. Which
sentence defines a drug’s half-life?
a. The time it takes for the drug to cause half of its therapeutic response
b. The time it takes for one half of the original amount of a drug to reach the target
cells
c. The time it takes for one half of the original amount of a drug to be removed from
the body
d. The time it takes for one half of the original amount of a drug to be absorbed into
the circulation
ANS: C
A drug’s half-life is the time it takes for one half of the original amount of a drug to be removed
from the body. It is a measure of the rate at which drugs are removed from the body. The other
options are incorrect definitions of half-life.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 27
TOP: NURSING PROCESS: General
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
, Chapter 02: Pharmacologic Principles 10
6. When administering drugs, the nurse remembers that the duration of action of a drug is defined
as which of these?
a. The time it takes for a drug to elicit a therapeutic response
b. The amount of time needed to remove a drug from circulation
c. The time it takes for a drug to achieve its maximum therapeutic response
d. The time period at which a drug’s concentration is sufficient to cause a therapeutic
response
ANS: D
Duration of action is the time during which drug concentration is sufficient to elicit a therapeutic
response. The other options do not define duration of action. A drug’s onset of action is the time
it takes for the drug to elicit a therapeutic response. A drug’s peak effect is the time it takes for
the drug to reach its maximum therapeutic response. Elimination is the length of time it takes to
remove a drug from circulation.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 28
TOP: NURSING PROCESS: General
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
7. When reviewing the mechanism of action of a specific drug, the nurse reads that the drug works
by selective enzyme interaction. Which of these processes describes selective enzyme
interaction?
a. The drug alters cell membrane permeability.
b. The drug’s effectiveness within the cell walls of the target tissue is enhanced.
c. The drug is attracted to a receptor on the cell wall, preventing an enzyme from
binding to that receptor.
d. The drug binds to an enzyme molecule and inhibits or enhances the enzyme’s
action with the normal target cell.
ANS: D
With selective enzyme interaction, the drug attracts the enzymes to bind with the drug instead of
allowing the enzymes to bind with their normal target cells. As a result, the target cells are
protected from the action of the enzymes. This results in a drug effect. The actions described in
the other options do not occur with selective enzyme interactions.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 29
TOP: NURSING PROCESS: General
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
8. When administering a new medication to a patient, the nurse reads that it is highly protein bound.
Assuming that the patient’s albumin levels are normal, the nurse would expect which result, as
compared to a medication that is not highly protein bound?
a. Renal excretion will be faster.
b. The drug will be metabolized quickly.
c. The duration of action of the medication will be shorter.
d. The duration of action of the medication will be longer.
ANS: D
